Trial Profile
Combination of mifepristone and misoprostol for termination of 8-16 weeks' pregancy: a multicenter, randomized controlled study.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 24 Apr 2016
Price :
$35
*
At a glance
- Drugs Mifepristone (Primary) ; Misoprostol (Primary) ; Misoprostol (Primary)
- Indications Induced abortion
- Focus Therapeutic Use
- 21 May 2012 Company (Shanghai Hualian Pharmaceutical) added as reported by Chinese Clinical Trial Register.
- 21 May 2012 Actual end date changed from May 2011 to Jun 2011 as reported by Chinese Clinical Trial Register record.
- 15 Nov 2011 Actual initiation date (1 Jul 2009) added as reported by Chinese Clinical Trial Register.